natgillin/translations-raw huggingface dataset:
By blocking factor Xa, it reduces the levels of thrombin in the blood, which reduces the risk of blood clots forming in the arteries and veins.
Inhibirajući faktor Xa, lijek smanjuje razine trombina u krvi, što smanjuje rizik od stvaranja krvnih ugrušaka u arterijama i venama.
By blocking NMDA receptors, memantine improves the transmission of signals in the brain and reduces the symptoms of Alzheimer’s disease.
Blokiranjem NMDA receptora, memantin poboljšava prijenos signala u mozgu i smanjuje simptome Alzheimerove bolesti.
By blocking NMDA receptors, memantine improves the transmission of signals in the brain and reduces the symptoms of Alzheimer’s disease.
Inhibirajući receptore NMDA, memantin poboljšava prijenos signala u mozgu i smanjuje simptome Alzheimerove bolesti.
By blocking PCSK9, Praluent increases the number of receptors available to help remove the “bad” cholesterol – this lowers your “bad” cholesterol levels.
Blokiranjem PCSK9, Praluent povećava broj receptora dostupnih za uklanjanje 'lošeg' kolesterola i tako snizuje vrijednosti 'lošeg' kolesterola.
By blocking PD-1, pembrolizumab prevents switching off these immune cells, thereby increasing the ability of the immune system to kill the cancer cells.
Inhibirajući djelovanje receptora PD-1 pembrolizumab sprječava isključivanje tih imunosnih stanica i time povećava sposobnost imunosnog sustava da ubija stanice raka.
By blocking reverse transcriptase, Genvoya reduces the amount of HIV-1 in the blood and keeps it at a low level.
Blokirajući reverznu transkriptazu Genvoya smanjuje količinu virusa HIV-1 u krvi i održava ga u malim koncentracijama.
By blocking the action of PDE4, roflumilast reduces the inflammation in the lungs, helping to reduce the patient’s symptoms or to prevent them from getting worse.
Blokiranjem djelovanja PDE4 roflumilast smanjuje upalu u plućima i time pomaže ublažiti simptome bolesnika ili spriječiti njihovo pogoršanje.
By blocking the action of SGLT2, canagliflozin causes more glucose to be removed via the urine, thereby reducing the levels of glucose in the blood.
Blokadom djelovanja SGLT2 kanagliflozin uzrokuje da se više glukoze uklanja urinom pa se tako reduciraju razine glukoze u krvi.
By blocking the action of SGLT2, dapagliflozin causes more glucose to be removed via the urine, thereby reducing the levels of glucose in the blood.
Inhibirajući djelovanje proteina SGLT2 dapagliflozin uzrokuje uklanjanje veće količine glukoze putem mokraće, te tako snižava razinu glukoze u krvi.
By blocking the action of SGLT2, dapagliflozin causes more glucose to be removed via the urine, thereby reducing the levels of glucose in the blood.
Inhibirajući djelovanje SGLT2, dapagliflozin uzrokuje uklanjanje veće količine glukoze putem urina, te stoga smanjuje razine glukoze u krvi.
By blocking the action of SGLT2, Edistride causes more glucose to be removed via the urine, thereby reducing the levels of glucose in the blood.
Inhibirajući djelovanje proteina SGLT2 Edistride uzrokuje uklanjanje veće količine glukoze putem mokraće, te tako snižava razinu glukoze u krvi.
By blocking the action of SGLT2, Jardiance causes more glucose to be removed via the urine, thereby reducing the levels of glucose in the blood.
Blokadom djelovanja SGLT2 Jardiance uzrokuje da se više glukoze uklanja urinom pa se tako reduciraju razine glukoze u krvi.
By blocking the action of these enzymes, Stivarga helps to restrict the growth and spread of the cancer.
Inhibiranjem djelovanja ovih enzima, Stivarga pomaže pri ograničavanju rasta i širenja karcinoma.
By blocking the action of these enzymes, tazobactam allows ceftolozane to act against bacteria that would otherwise be resistant.
Inhibirajući djelovanje ovih enzima, tazobaktam omogućuje ceftolozanu da djeluje protiv bakterija koje bi u suprotnom bile otporne.
By blocking the action of this protein, empagliflozin causes more glucose to be removed via the urine, thereby reducing the levels of glucose in the blood.
Inhibirajući djelovanje te bjelančevine, empagliflozin uzrokuje uklanjanje veće količine glukoze putem mokraće, te tako snižava razine glukoze u krvi.
By blocking the actions of substance P and serotonin in this way, the medicines help prevent the stimulation of the vomiting centre and the resulting sickness.
Takvim blokiranjem djelovanja tvari P i serotonina, lijek pomaže u sprječavanju poticanja centra za povraćanje i posljedične mučnine.
By blocking the activity of IL-1 beta, Ilaris may lead to an improvement in these symptoms.
Blokiranjem aktivnosti IL-1 beta Ilaris može dovesti do ublažavanja tih simptoma.
By blocking the activity of these enzymes in cancer cells, the medicine reduces the growth and spread of the cancer.
Onemogućivanjem djelovanja tih enzima u stanicama raka, lijek smanjuje rast i širenje raka.
By blocking the breakdown of incretin hormones in the blood, alogliptin prolongs their action in stimulating the pancreas to produce more insulin when blood
Inhibiranjem razgradnje inkretinskih hormona u krvi, alogliptin produžuje njihovo djelovanje pri stimulaciji gušterače kako bi gušterača proizvela više inzulina kada su
By blocking the C5 complement protein, eculizumab prevents complement proteins from damaging the blood cells, thereby helping to relieve the symptoms of the disease.
Inhibirajući komplementski protein C5, ekulizumab sprječava komplementske proteine da oštećuju krvne stanice, te tako pridonosi ublažavanju simptoma bolesti.
By blocking the effect of endothelin, Volibris allows the vessels to dilate (expand), helping to lower the blood pressure and improving symptoms.
Blokiranjem učinaka endotelina Volibris omogućuje opuštanje (širenje) žila, što pomaže u snižavanju krvnog tlaka i poboljšanju simptoma.
By blocking the effect of LHRH, Cetrotide stops the production of LH, and therefore prevents premature ovulation, which can result in the release of eggs that are immature and unsuitable for use in techniques such as in vitro fertilisation (IVF).
Blokiranjem učinka LHRH-a, lijek Cetrotide zaustavlja proizvodnju LH-a te time sprečava prijevremenu ovulaciju koja može dovesti do otpuštanja jajašaca koja su nezrela i koja nisu prikladna za uporabu u tehnikama kao što je in vitro oplodnja (IVF).
By blocking the enzyme, cancer cells are prevented from multiplying and they eventually die.
Kada je enzim blokiran, spriječeno je umnožavanje stanica raka i one naposljetku umiru.
By blocking the production of angiotensin I, levels of both angiotensin I and angiotensin II fall.
Kako se onemogućuje stvaranje angiotenzina I, razine angiotenzina I i angiotenzina II se snižavaju.
By blocking the production of angiotensin I, levels of both angiotensin I and angiotensin II fall.
Onemogućavanjem stvaranja angiotenzina I razine angiotenzina I i angiotenzina II se snižavaju.
By blocking the receptors to which angiotensin II normally attaches, valsartan stops the hormone’s harmful effects on the heart and it also reduces blood pressure by allowing blood vessels to widen.
Valsartan blokiranjem receptora na koje se angiotenzin II inače vezuje zaustavlja štetne učinke koje taj hormon ima na srce te također smanjuje krvni tlak omogućivanjem širenja krvnih žila.
By blocking the receptors, Somavert prevents growth hormone from having an effect, thereby preventing the unwanted growth and other disorders seen in acromegaly.
Inhibirajući te receptore Somavert sprječava djelovanje hormona rasta i tako sprječava neželjen rast i druge poremećaje koji su uočeni u slučaju akromegalije.
By blocking their action, tazobactam makes ceftolozane more effective at killing bacteria.
Blokiranjem njihovog djelovanja tazobaktam povećava učinkovitost ceftolozana u uništavanju bakterija.
By blocking these enzymes, Exelon allows levels of acetylcholine to be increased in the brain, helping to reduce the symptoms of Alzheimer’s disease and dementia associated with Parkinson’s disease.
Blokiranjem tih enzima, Exelon omogućava povećavanje koncentracije acetilkolina u mozgu te tako pomaže u smanjivanju simptoma Alzheimerove bolesti i demencije povezane s Parkinsonovom bolešću.
By blocking these enzymes, Exelon allows levels of acetylcholine to be increased in the brain, helping to reduce the symptoms of Alzheimer’s disease.
Blokiranjem tih enzima Exelon omogućava povećavanje koncentracije acetilkolina u mozgu te tako pomaže u smanjivanju simptoma Alzheimerove bolesti.
By blocking these enzymes, lenvatinib can block the formation of new blood vessels and hence cut off the blood supply that keeps cancer cells growing, and reduce their growth.
Inhibirajući te enzime, lenvatinib može inhibirati formiranje novih krvnih žila i prekinuti opskrbu krvlju, što sprječava rast stanica raka i smanjuje njihov rast.
By blocking these enzymes, Nimvastid allows levels of acetylcholine to be increased in the brain, helping to reduce the symptoms of Alzheimer’s disease and dementia associated with Parkinson’s disease.
Blokiranjem tih enzima, Nimvastid omogućava povećavanje koncentracije acetilkolina u mozgu te tako pomaže u smanjivanju simptoma Alzheimerove bolesti i demencije povezane s Parkinsonovom bolešću.
By blocking these enzymes, Prometax allows levels of acetylcholine to be increased in the brain, helping to reduce the symptoms of Alzheimer’s disease and dementia associated with Parkinson’s disease.
Blokiranjem tih enzima, Prometax omogućava povećavanje koncentracije acetilkolina u mozgu te tako pomaže u smanjivanju simptoma Alzheimerove bolesti i demencije povezane s Parkinsonovom bolešću.
By blocking these enzymes, Prometax allows levels of acetylcholine to be increased in the brain, helping to reduce the symptoms of Alzheimer’s disease.
Blokiranjem tih enzima Prometax omogućava povećavanje koncentracije acetilkolina u mozgu te tako pomaže u smanjivanju simptoma Alzheimerove bolesti.
By blocking these enzymes, Rivastigmine 1 A Pharma allows levels of acetylcholine to be increased in the brain, helping to reduce the symptoms of Alzheimer’s disease and dementia associated with Parkinson’s disease.
Rivastigmin 1 A Pharma omogućava povećanje razina acetilkolina u mozgu, što pomaže u smanjivanju simptoma Alzheimerove bolesti i demencije povezane s Parkinsovom bolešću.
By blocking these enzymes, Rivastigmine 3M Health Care Ltd allows levels of acetylcholine to be increased in the brain, helping to reduce the symptoms of Alzheimer’s dementia.
Blokirajući ove enzime, Rivastigmine 3M Health Care Ltd omogućuje povišenje razina acetilkolina u mozgu, pomažući pri smanjivanju simptoma ing to Alzheimerove demencije.
By blocking these enzymes, Rivastigmine 3M Health Care Ltd. allows levels of acetylcholine to be increased in the brain, helping to reduce the symptoms of Alzheimer’s disease.
Blokiranjem tih enzima Rivastigmin 3M Health Care Ltd. omogućava povećavanje koncentracije acetilkolina u mozgu te tako pomaže u smanjivanju simptoma Alzheimerove bolesti.
By blocking these enzymes, Rivastigmine Actavis allows levels of acetylcholine to be increased in the brain, helping to reduce the symptoms of Alzheimer’s disease and dementia associated with Parkinson’s disease.
Blokiranjem tih enzima, Rivastigmin Actavis omogućava povećavanje koncentracije acetilkolina u mozgu te tako pomaže u smanjivanju simptoma Alzheimerove bolesti i demencije povezane s Parkinsonovom bolešću.
By blocking these enzymes, Rivastigmine allows levels of acetylcholine to be increased in the brain, helping to reduce the symptoms of Alzheimer’s disease and dementia associated with Parkinson’s disease.
Blokirajući te enzime, Rivastigmin HEXAL omogućava povećanje razina acetilkolina u mozgu, što pomaže u smanjivanju simptoma Alzheimerove bolesti i demencije povezane s Parkinsovom bolešću.
By blocking these enzymes, Rivastigmine HEXAL allows levels of acetylcholine to be increased in the brain, helping to reduce the symptoms of Alzheimer’s disease and dementia associated with Parkinson’s disease.
Blokirajući te enzime, Rivastigmin HEXAL omogućava povećanje razina acetilkolina u mozgu, što pomaže u smanjivanju simptoma Alzheimerove bolesti i demencije povezane s Parkinsovom bolešću.
By blocking these enzymes, Rivastigmine Sandoz allows levels of acetylcholine to be increased in the brain, helping to reduce the symptoms of Alzheimer’s disease and dementia associated with Parkinson’s disease.
Blokirajući te enzime, Rivastigmin Sandoz omogućava povećanje razina acetilkolina u mozgu, što pomaže u smanjivanju simptoma Alzheimerove bolesti i demencije povezane s Parkinsovom bolešću.
By blocking these factors, aflibercept reduces the growth of the blood vessels and controls the leakage and swelling.
Blokiranjem ovih faktora aflibercept smanjuje rast krvnih žila, te kontrolira iscjedak i oticanje.
By blocking these proteins, the medicine prevents the hepatitis C virus from multiplying and infecting new cells.
Blokiranjem tih bjelančevina, lijek zaustavlja umnožavanje virusa hepatitisa C i inficiranje novih stanica.
By blocking these receptors, Imatinib Accord helps to control cell division.
Blokirajući ove receptore, lijek Imatinib Accord pomaže u kontroli podjele stanica.
By blocking these receptors, Imatinib Actavis helps to control cell division.
Blokirajući ove receptore, lijek Imatinib Actavis pomaže u kontroli diobe stanica.
By blocking these receptors, Relistor reduces the constipation due to opioids, but does not interfere with their painkilling effects.
Inhibirajući ove receptore, Relistor smanjuje zatvor uslijed opioida, no ne interferira s njihovim analgetičkim djelovanjem.
By blocking these receptors, Tyverb helps to control cell division and growth of the cancer.
Inhibirajući ove receptore Tyverb pomaže pri kontroli diobe stanica i rasta karcinoma.
By blocking this enzyme, Intelence, taken in combination with other anti-HIV medicines, reduces the amount of HIV in the blood and keeps it at a low level.
Blokiranjem ovog enzima, Intelence, koji se uzima zajedno s drugim lijekovima protiv HIV-a, smanjuje količinu HIV-a u krvi te održava ove razine niskima.
By blocking this enzyme, Stocrin, taken in combination with other antiviral medicines, reduces the amount of HIV in the blood and keeps it at a low level.
Blokiranjem ovog enzima, Stocrin, koji se uzima zajedno s drugim antiviroticima, snižava količinu HIV-a u krvi te je održava na niskoj razini.
By blocking this enzyme, Sustiva, taken in combination with other antiviral medicines, reduces the amount of HIV in the blood and keeps it at a low level.
Blokiranjem ovog enzima, lijek Sustiva, koji se uzima zajedno s drugim antiviroticima, snižava količinu HIV-a u krvi te je održava na niskoj razini.
By blocking this factor, ranibizumab reduces the growth of the blood vessels and controls the leakage and swelling.
Blokadom ovog čimbenika ranibizumab smanjuje rast krvnih žila i kontrolira propuštanje i oticanje.
By blocking TNF-alpha, certolizumab pegol reduces the inflammation and other symptoms of the diseases.
Inhibiranjem TNF-alfe, certolizumabpegol smanjuje upalu i druge simptome bolesti.
By blocking TNF-, golimumab reduces the inflammation and other symptoms of these diseases.
Blokadom TNF- golimumab smanjuje upalu i druge simptome tih bolesti.
By comparison, vorapaxar exposure (AUC and Cmax) is estimated to be 19-21% lower in patients with a body weight of >100 kg compared to those weighing 60-100 kg.
Za usporedbu, procjenjuje se da je izloženost vorapaksaru (AUC i Cmax) 19-21% niža u bolesnika tjelesne težine >100 kg u odnosu na one čija je tjelesna težina 60-100 kg.
by conivaptan
konivaptano
By continuously breathing the patient must pull out the straw and immediately close the breath bag with its stopper.
Stalnim izdisanjem bolesnik treba izvlačiti slamčicu i odmah zatvoriti vrećicu za izdahunuti zrak čepom.
By continuously breathing the patient must pull out the straw and immediately close the breath sample container (tube or breath bag) with its stopper.
Stalnim izdisanjem bolesnik treba izvlačiti slamčicu i odmah zatvoriti spremnik za uzorak izdahnutog zraka (epruvetu ili vrećicu za izdahnuti zrak) čepom.
By continuously breathing the patient must pull out the straw and immediately close the sample tube with its stopper.
Stalnim izdisanjem bolesnik treba izvlačiti slamčicu i odmah zatvoriti epruvetu za uzimanje uzoraka čepom.
By continuously breathing the patient must pull out the straw and immediately close the sample tube with its stopper.
Stalnim izdisanjem bolesnik treba izvlačiti slamčicu i odmah zatvoriti epruvetu za za uzimanje uzoraka čepom.
By contrast, telbivudine-5'-triphosphate at concentrations up to 100 M did not inhibit cellular DNA polymerases , , or .
Nasuprot tome, telbivudin- 5'-trifosfat u koncentracijama do 100 M nije inhibirao staničnu DNK polimerazu ,  ni .
By contrast, ventricular arrhythmias were reported with similar frequencies in patients without a history of CHF who were treated with either BRINAVESS or placebo (3.2% for BRINAVESS versus 3.6% for placebo).
Nasuprot tomu, prijavljena učestalost ventrikularnih aritmija u bolesnika bez kongestivnog zatajenja srca koji su primili BRINAVESS bila je slična onoj u bolesnika koji su primili placebo (3,2% za BRINAVESS naspram 3,6% za placebo).
By Day 14, combined plasma concentrations of sunitinib and is active metabolite are 62.9 - 101 ng/ml which are target concentrations predicted from preclinical data to inhibit receptor phosphorylation in vitro and result in tumour stasis/growth reduction in vivo.
Do 14. dana kombinirane plazmatske koncentracije sunitiniba i njegova aktivnog metabolita iznose 62,9-101 ng/ml, što su ciljne koncentracije koje, prema podacima iz pretkliničkih istraživanja, inhibiraju fosforilaciju receptora in vitro te rezultiraju stazom/smanjenjem rasta tumora in vivo.
By expanding these blood vessels, the blood pressure is reduced and symptoms are improved.
Širenjem ovih krvnih žila, krvni tlak se smanjuje, a simptomi se poboljšavaju.
By extrapolation from clinical data on combination therapy with standard interferon in paediatric patients (negative predictive value 96 % for interferon alfa–2b/ribavirin), patients who fail to achieve virological response at 12 weeks are highly unlikely to become sustained virological responders.
Ekstrapolacija iz kliničkih podataka za kombiniranu terapiju sa standardnim interferonom u pedijatrijskih bolesnika (negativna prediktivna vrijednost 96% za interferon alfa-2b/ribavirin) ukazuje da bolesnici koji nisu postigli virološki odgovor u 12. tjednu terapije najvjerojatnije neće postići trajan virološki odgovor.
By extrapolation from erythromycin A and josamycin, concomitant medication of Ketek and alkaloid derivatives could lead to severe vasoconstriction (“ergotism”) with possibly necrosis of the extremities.
Sudeći prema iskustvu s eritromicinom A i josamicinom, istodobna primjena lijeka Ketek i derivata alkaloida može dovesti do teške vazokonstrikcije ("ergotizma") s mogućom nekrozom udova.
By increasing levels of dopamine in the parts of the brain that control movement and co-ordination, Azilect improves the signs and symptoms of Parkinson’s disease, such as stiffness and slowness of movement.
Povećanjem razina dopamina u dijelovima mozga koji kontroliraju kretanje i koordinaciju, lijek Azilect poboljšava znakove i simptome Parkinsonove bolesti kao što su ukočenost i usporeno kretanje.
By increasing levels of dopamine in the parts of the brain that control movement and coordination, Rasagiline Mylan reduces the symptoms of Parkinson’s disease, such as stiffness and slowness of movement.
Povećanjem razina dopamina u dijelovima mozga koji kontroliraju kretanje i koordinaciju, lijek Rasagiline Mylan smanjuje simptome Parkinsonove bolesti kao što su ukočenost i usporeno kretanje.
By increasing levels of dopamine in the parts of the brain that control movement and coordination, Rasagiline ratiopharm improves the signs and symptoms of Parkinson’s disease, such as stiffness and slowness of movement.
Povećavajući razine dopamina u dijelovima mozga koji kontroliraju pokret i koordinaciju, Razagilin ratiopharm poboljšava znakove i simptome Parkinsonove bolesti, poput ukočenosti i usporenih pokreta.
By inhibiting SGLT2, canagliflozin reduces reabsorption of filtered glucose and lowers the renal threshold for glucose (RTG), and thereby increases UGE, lowering elevated plasma glucose concentrations by this insulin-independent mechanism in patients with type 2 diabetes.
Inhibirajući SGLT2, kanagliflozin smanjuje reapsorpciju filtrirane glukoze i smanjuje prag bubrega za glukozu (RTG), na taj način povisuje UGE, smanjujući povišene koncentracije glukoze u plazmi putem ovog o inzulinu neovisnog mehanizma u bolesnika s dijabetesom tipa 2.
By inhibiting the binding of PCSK9 to LDLR, alirocumab increases the number of LDLRs available to clear LDL, thereby lowering LDL-C levels.
Inhibiranjem vezivanja PCSK9 za LDLR, alirokumab povećava broj LDLR-a dostupnih za odstranjivanje LDL-a i na taj način snizuje vrijednosti LDL-C.
By inhibiting the enzyme renin, aliskiren inhibits the RAAS at the point of activation, blocking the conversion of angiotensinogen to angiotensin I and decreasing levels of angiotensin I and angiotensin II.
Inhibiranjem enzima renina aliskiren inhibira RAAS u trenutku aktivacije blokirajući konverziju angiotenzinogena u angiotenzin I i snižavajući razine angiotenzina I i angiotenzina II.
By inhibiting the enzyme renin, aliskiren inhibits the RAAS at the point of activation, blocking the conversion of angiotensinogen to angiotensin I and decreasing levels of angiotensin I and angiotensin II.
Inhibiranjem enzima renina aliskiren inhibira RAAS u trenutku aktivacije, blokirajući konverziju angiotenzinogena u angiotenzin I i snižavajući razine angiotenzina I i angiotenzina II.
By interfering with enterohepatic circulation of the drug, bile acid sequestrants such as cholestyramine, reduce MPA AUC (see section 4.9).
Interferencijom s enterohepatičnom cirkulacijom lijeka, lijekovi za snižavanje razine žučnih kiselina, poput kolestiramina, snizuju AUC MPA (vidjeti dio 4.9).
By intravenous route, the LD50 in rats and mice ranges between 30 and 60 mg/kg.
Kod intravenskog načina primjene u miševa i štakora LD50 iznosi između 30 i 60 mg/kg.
by Kaletra.
Lamotrigin:
By looking though the inspection window, the solution should be clear to slightly opalescent, colourless or pale yellow and may contain small translucent or white particles of protein.
Pogledom na prozorčić za provjeru izgleda otopine, otopina mora biti bistra do blago opalescentna, bezbojna ili svijetložuta i može sadržavati male prozirne ili bijele dijelove proteina.
by lopinavir
ombitasviro
By lowering blood pressure, the risk caused by high blood pressure, such as having a stroke, is reduced.
Snižavanjem krvnog tlaka, smanjuje se i rizik koji uzrokuje visoki krvi tlak, poput moždanog udara.
By lowering the heart rate, Corlentor reduces the stress on the heart, thereby slowing the progression of heart failure and improving symptoms.
Snižavanjem srčane frekvencije, Corlentor smanjuje stres na srcu, te stoga usporava napredak zatajenja srca i poboljšava simptome.
By lowering the heart rate, Ivabradine Anpharm reduces the stress on the heart, thereby slowing the progression of heart failure and improving symptoms.
Snižavanjem srčane frekvencije, Ivabradine Anpharm smanjuje stres na srcu, te stoga usporava napredak zatajenja srca i poboljšava simptome
By lowering the heart rate, Procoralan reduces the stress on the heart, thereby slowing the progression of heart failure and improving symptoms.
Snižavanjem srčane frekvencije, Procoralan smanjuje stres na srcu, te stoga usporava napredak zatajenja srca i poboljšava simptome.
By lowering the pressure, Izba reduces the risk of damage.
Izba smanjuje rizik od oštećenja snižavanjem tlaka.
By mimicking the action of thrombopoietin, romiplostim stimulates the production of platelets, increasing blood platelet counts.
Oponašajući djelovanje trombopoetina, romiplostim stimulira stvaranje trombocita povećavajući broj trombocita u krvi.
by modestly increasing insulin sensitivity, improving peripheral glucose uptake and utilisation in muscle; by delaying intestinal glucose absorption.
umjereno povećavajući osjetljivost na inzulin, čime se poboljšava unos i iskorištavanje glukoze u perifernim tkivima u mišićima, usporavajući apsorpciju glukoze u crijevima.